Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol and Paclitaxel in Paclitaxel-Refractory Esophageal Cancer
NCT00006245Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of alvocidib in esophageal cancer, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Response Rate. Started Jul 2000; status: completed.
02
Drugs
alvocidib
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00006245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006245.